Abstract
BACKGROUND & AIMS: Gemcitabine resistance is rapidly acquired by pancreatic ductal adenocarcinoma (PDAC) patients. Novel approaches that predict t......
小提示:本篇文献需要登录阅读全文,点击跳转登录